What Is Building-Related Illness
Building-Related Illness (BRI) is a diagnosable medical condition with a specific cause traceable to airborne contaminants or biological agents in a building. Unlike general symptoms, BRI has clinical markers that a physician can identify through testing and examination. Common examples include Legionnaires' disease from Legionella bacteria in water systems, histoplasmosis from fungal spores, and hypersensitivity pneumonitis from repeated mold exposure.
In mold-affected buildings, the primary concern is hypersensitivity pneumonitis and aspergillosis. Both occur when occupants inhale mold spores or mycotoxins at levels sufficient to trigger an immune response or infection. The EPA recognizes mold as a significant indoor air quality hazard, particularly in homes with water intrusion, high humidity (above 60%), or poor ventilation.
BRI vs. Sick Building Syndrome
It's critical to distinguish BRI from Sick Building Syndrome (SBS). BRI has a definable biological or chemical cause and produces measurable clinical findings. SBS involves non-specific symptoms like headaches and fatigue with no identifiable medical cause. A building can trigger both simultaneously. If occupants develop persistent cough, shortness of breath, and fever that improves after leaving the building, that points to BRI. Testing should include air sampling, surface sampling, and moisture assessment to establish the connection.
Detection and Testing Protocols
Identifying BRI requires a systematic approach. Your inspector should conduct moisture mapping using moisture meters to locate water damage behind walls and under floors. Air testing typically uses spore traps or cassettes to collect mold particles over 24 hours, with results compared against outdoor baseline levels. The EPA does not set mandatory mold thresholds for indoor air, but spore counts exceeding outdoor levels by a factor of 1.5 to 2.0 warrant concern.
Surface sampling via tape lifts or swabs can identify active mold colonies. Bulk sampling removes material directly for laboratory analysis. Your physician may request immunological testing if hypersensitivity pneumonitis is suspected, measuring antibodies specific to mold antigens.
Remediation Protocol
Addressing BRI requires moisture control first. The EPA and CDC recommend keeping indoor humidity below 50-60% and fixing water leaks within 24 to 48 hours. Professional remediation involves containment (plastic sheeting and HEPA filtration), removal of contaminated materials, and biocide application if warranted. Post-remediation verification testing confirms that spore counts have returned to outdoor baseline levels.
A qualified remediation contractor (certified by IICRC or NORMI standards) should oversee this work. Incomplete remediation leaves mold and moisture problems intact, perpetuating BRI symptoms.
Health Effects and Documentation
Occupants with confirmed mold exposure and clinical symptoms should maintain medical records documenting the onset, severity, and resolution of symptoms. This record strengthens claims if insurance or legal issues arise. Share your physician's findings with your remediation team and inspector to ensure the scope of work addresses the root cause.
Common Questions
- Can I remediate mold myself to avoid BRI? Minor surface mold (under 10 square feet) can be cleaned with detergent and water if the underlying moisture source is fixed. Larger infestations and HVAC contamination require professional containment and removal to prevent spore spread and incomplete remediation.
- What humidity level protects against mold-related BRI? Keep interior humidity between 30% and 50%. Aim for the lower end if you have a history of mold or water intrusion. Use a hygrometer to monitor levels and adjust dehumidifiers or ventilation as needed.
- How long does it take for symptoms to resolve after remediation? This varies. Some occupants see improvement within weeks; others need months for respiratory or immune symptoms to fully clear. Continued exposure to moisture problems will delay recovery.